Cited by 504Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women

Cook, Nancy R., Buring, Julie E., Ridker, Paul M·2006·Annals of Internal Medicine

DOI 10.7326/0003-4819-145-1-200607040-00128

Open this paper in CoChat — free account

Abstract

BACKGROUND: While high-sensitivity C-reactive protein (hsCRP) is an independent predictor of cardiovascular risk, global risk prediction models incorporating hsCRP have not been developed for clinical use. OBJECTIVE: To develop and compare global cardiovascular risk prediction models with and without hsCRP. DESIGN: Observational cohort study. SETTING: U.S. female health professionals. PARTICIPANTS: Initially healthy nondiabetic women age 45 years and older participating in the Women's Health Study and followed an average of 10 years. MEASUREMENTS: Incident cardiovascular events (myocardial infarction, stroke, coronary revascularization, and cardiovascular death). RESULTS: High-sensitivity CRP made a relative contribution to global risk at least as large as that provided by total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol individually, but less than that provided by age, smoking, and blood pressure. All global measures of fit improved when hsCRP was included, with likelihood-based measures demonstrating strong preference for models that include hsCRP. With use of 10-year risk categories of 0% to less than 5%, 5% to less than 10%, 10% to less than 20%, and 20% or greater, risk prediction was more accurate in models that included hsCRP, particularly for risk between 5% and 20%. Among women initially classified with risks of 5% to less than 10% and 10% to less than 20% according to the Adult Treatment Panel III covariables, 21% and 19%, respectively, were reclassified into more accurate risk categories. Although addition of hsCRP had minimal effect on the c-statistic (a measure of model discrimination) once age, smoking, and blood pressure were accounted for, the effect was nonetheless greater than that of total, LDL, or HDL cholesterol, suggesting that the c-statistic may be insensitive in evaluating risk prediction models. LIMITATIONS: Data were available only for women. CONCLUSIONS: A global risk prediction model that includes hsCRP improves cardiovascular risk classification in women, particularly among those with a 10-year risk of 5% to 20%. In models that include age, blood pressure, and smoking status, hsCRP improves prediction at least as much as do lipid measures.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-145-1-200607040-00128

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401

Show all 50 references

Research works printed but not linked: 3

Buring JE, 1992, Journal of Myocardial Ischemia, 4, 27
Nagelkerke NJ, 1991, Biomka, 78, 691
Boekholdt SM, 2005, Atherosclerosis

Sorted by citations

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,167
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,976
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,348
A combined comorbidity score predicted mortality in elderly patients better than existing scores
Gagne, J. J., Glynn, R. J., Avorn, J., Levin, R., & Schneeweiss, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.004 · Cited by 995
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A. O., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 893
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men
Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R. (2008) · Circulation · doi:10.1161/circulationaha.108.814251 · Cited by 841
Self-citation
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis
Erbel, R. M., Möhlenkamp, S., Moebus, S., Schmermund, A., Lehmann, N., Stang, A., Dragano, N., Grönemeyer, D. H. W., Seibel, R. M. M., Kälsch, H., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.030 · Cited by 783
Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve
Cook, N. R. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.096529 · Cited by 697
Women and Ischemic Heart Disease
Shaw, L. J., Bugiardini, R., & Merz, C. N. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.098 · Cited by 669
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
Mayers, J. R., Wu, C. H., Clish, C. B., Kraft, P. L., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 672
Characterizing the profile of obese patients who are metabolically healthy
Primeau, V., Coderre, L., Karelis, A. D., Brochu, M., Lavoie, M.-È., Messier, V., SLADEK, R. M., & RABASA-LHORET, R. P. R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.216 · Cited by 648
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 635
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
Ingelsson, E., Schaefer, E. J., Contois, J. H., McNamara, J. R., Sullivan, L., Keyes, M. J., Pencina, M. J., Schoonmaker, C., Wilson, P. W. F., D’Agostino, R. B., et al. (2007) · JAMA · doi:10.1001/jama.298.7.776 · Cited by 608
Net Reclassification Improvement: Computation, Interpretation, and Controversies: A Literature Review and Clinician's Guide
Leening, M. J. G., Vedder, M. M., Witteman, J. C. M., Pencina, M. J., & Steyerberg, E. W. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1522 · Cited by 594
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
Buckley, D., Fu, R. F., Freeman, M., Rogers, K. R., & Helfand, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00009 · Cited by 561
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 549
Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model
Tice, J. A., Cummings, S. R., Smith‐Bindman, R., Ichikawa, L., Barlow, W. E., & Kerlikowske, K. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00004 · Cited by 527
Exercise as a Mean to Control Low‐Grade Systemic Inflammation
Mathur, N., & Pedersen, B. K. (2008) · Mediators of Inflammation · doi:10.1155/2008/109502 · Cited by 514
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O. K., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 505
C-Reactive Protein/Albumin Ratio Predicts 90-Day Mortality of Septic Patients
Ranzani, O., Zampieri, F. G., Forte, D. N., Azevedo, L. C. P., & Park, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059321 · Cited by 482
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Cook, N. R., & Ridker, P. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00007 · Cited by 458
Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals
Meuwese, M. C., Stroes, E. S. G., Hazen, S. L., van Miert, J. N. I., Kuivenhoven, J. A., Schaub, R. G., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.033 · Cited by 444
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data
Uno, H., Tian, L., Cai, T., Kohane, I. S., & Wei, L. J. (2012) · Statistics in Medicine · doi:10.1002/sim.5647 · Cited by 390
Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand, M., Buckley, D., Freeman, M., Fu, R. F., Rogers, K. R., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 383
Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly
Elias‐Smale, S. E., Vliegenthart, R., Koller, M., Kavousi, M., van Rooij, F. J. A., Hunink, M. G. M., Steyerberg, E. W., Albert Hofman, D., Oudkerk, M., & Witteman, J. C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.029 · Cited by 369
C‐reactive protein and coronary heart disease: a critical review
Casas, J. P., Shah, T., Hingorani, A. D., Danesh, J., & Pepys, M. B. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02015.x · Cited by 367
Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality
Cao, J. J., Arnold, A. M., Manolio, T. A., Polak, J. F., Psaty, B. M., Hirsch, C. H., Kuller, L. H., & Cushman, M. (2007) · Circulation · doi:10.1161/circulationaha.106.645606 · Cited by 348
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.831198 · Cited by 299
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes
Buijsse, B., Simmons, R. K., Griffin, S. J., & Schulze, M. B. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq019 · Cited by 297
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Wang, T. J. (2011) · Circulation · doi:10.1161/circulationaha.109.912568 · Cited by 299
Integrating the Predictiveness of a Marker with Its Performance as a Classifier
Pepe, M. S., Feng, Z., Huang, Y., Longton, G., Prentice, R. L., Thompson, I. M., & Zheng, Y. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm305 · Cited by 291
Human C-reactive protein and the metabolic syndrome
Devaraj, S., Singh, U. S., & Jialal, I. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ac03e · Cited by 295
Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position Paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology
Vaccarino, V., Badimón, L., Corti, R., de Wit, C., Dorobanţu, M., Hall, A. S., Koller, Á., Marzilli, M., PRIES, A. R., Bugiardini, R., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq394 · Cited by 287
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Singh, S., Singh, H., Loftus, E. V., & Pardi, D. S. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.08.023 · Cited by 281
Assessment of claims of improved prediction beyond the Framingham risk score.
Tzoulaki, I., Liberopoulos, G., & Ioannidis, J. (2009) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2009.1757 · Cited by 281
Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative
Cook, N. R., Paynter, N. P., Eaton, C. B., Manson, J. E., Martin, L. W., Robinson, J. G., Rossouw, J. E., Wassertheil-Smoller, S. W., & Ridker, P. M. (2012) · Circulation · doi:10.1161/circulationaha.111.075929 · Cited by 266
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science
McSweeney, J. C., Rosenfeld, A. G., Abel, W. M., Braun, L. T., Burke, L. E., Daugherty, S. L., Fletcher, G. F., Gulati, M., Mehta, L. S., Bricker, C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000381 · Cited by 276
Assessing the Value of Risk Predictions by Using Risk Stratification Tables
Janes, H., PEPE, M. S., & Gu, W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00009 · Cited by 249
Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke
Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · Circulation · doi:10.1161/circulationaha.106.635029 · Cited by 238
Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts
Shah, T., Casas, J. P., Cooper, J. A., Tzoulaki, I., Sofat, R., McCormack, V., Smeeth, L. L., Deanfield, J. E., Lowe, G. D. O., Rumley, A., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn217 · Cited by 234
C-reactive protein is a mediator of cardiovascular disease
Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq238 · Cited by 230
Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?
Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222
A history of preeclampsia identifies women who have underlying cardiovascular risk factors
Smith, G. N., WALKER, M. C., Liu, A., Wen, S. W., Swansburg, M. L., Ramshaw, H., White, R. R., Roddy, M., & Hladunewich, M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.035 · Cited by 224
Consumption of a healthy dietary pattern results in significant reductions in C-reactive protein levels in adults: a meta-analysis
Neale, E. P., Batterham, M. J., & Tapsell, L. C. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.02.009 · Cited by 220
Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals
Lefevre, M., Redman, L. M., Heilbronn, L. K., Smith, J. V., Martin, C. K., Rood, J. C., Greenway, F. L., Williamson, D. A., Smith, S. R., & Ravussin, E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.036 · Cited by 217
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2018) · JAMA · doi:10.1001/jama.2018.8359 · Cited by 232
Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Lin, J. S., Evans, C. V., Johnson, E., Redmond, N., Coppola, E. L., & Smith, N. (2018) · JAMA · doi:10.1001/jama.2018.4242 · Cited by 216
C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease
Ridker, P. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.119214 · Cited by 206
High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese
Arima, H., Kubo, M., Yonemoto, K., Doi, Y., Ninomiya, T., Tanizaki, Y., Hata, J., Matsumura, K., Iida, M., & Kiyohara, Y. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.157164 · Cited by 205
Quantifying the added value of new biomarkers: how and how not
Cook, N. R. (2018) · Diagnostic and Prognostic Research · doi:10.1186/s41512-018-0037-2 · Cited by 198
Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Listing, J., Strangfeld, A., Kekow, J., Schneider, M., Kapelle, A., Wassenberg, S., & Zink, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23281 · Cited by 196
Waist Circumference Measurement in Clinical Practice
Ness-Abramof, R., & Apovian, C. M. (2008) · Nutrition in Clinical Practice · doi:10.1177/0884533608321700 · Cited by 205
Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples*
van der Steeg, J. W., Steures, P., Eijkemans, M. J. C., Habbema, J. D. F., Hompes, P. G. A., Broekmans, F. J., van Dessel, H. J. H. M., Bossuyt, P. M., van der Veen, F., & Mol, B. W. (2006) · Human Reproduction · doi:10.1093/humrep/del378 · Cited by 192
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
The Emerging Risk Factors Collaboration (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9165-7 · Cited by 192
Age as a modifiable risk factor for cardiovascular disease
Sniderman, A. D., & Furberg, C. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60313-x · Cited by 187
Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: Insights from the National Health and Nutrition Examination Survey-III
Shah, N. N., Parikh, V. K., Patel, N., Patel, N., Badheka, A., Deshmukh, A. J., Rathod, A. D., & Lafferty, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.019 · Cited by 184
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis
Montellano, F. A., Ungethüm, K., Ramiro, L., Nacu, A., Hellwig, S., Fluri, F., Whiteley, W. N., Bustamante, A., Montaner, J., & Heuschmann, P. U. (2021) · Stroke · doi:10.1161/strokeaha.120.029232 · Cited by 179
Cardiovascular risk assessment scores for people with diabetes: a systematic review
Chamnan, P., Simmons, R. K., Sharp, S. J., Griffin, S. J., & Wareham, N. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1454-0 · Cited by 176
C-Reactive Protein and Prediction of 1-Year Mortality in Prevalent Hemodialysis Patients
Bazeley, J. W., Bieber, B. A., Li, Y., Morgenstern, H., de Sequera, P., Combe, C., Yamamoto, H., Gallagher, M., Port, F. K., & Robinson, B. M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00710111 · Cited by 178
The Methods of Comparative Effectiveness Research
Sox, H. C., & Goodman, S. N. (2012) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031811-124610 · Cited by 181
Quantification of Coronary Atherosclerosis and Inflammation to Predict Coronary Events and All-Cause Mortality
Möhlenkamp, S., Lehmann, N., Moebus, S., Schmermund, A., Dragano, N., Stang, A., Siegrist, J., Mann, K., Jöckel, K., & Erbel, R. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.043 · Cited by 171
Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical InformationPreprint
Mealiffe, M. E., Stokowski, R. P., Rhees, B. K., Prentice, R. L., Pettinger, M. B., & Hinds, D. A. (2010) · Nature Precedings · doi:10.1093/jnci/djq388 · Cited by 168
The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml
Carmel, A., Shieh, A., Bang, H., & Bockman, R. S. (2012) · Osteoporosis International · doi:10.1007/s00198-011-1868-7 · Cited by 160
Evaluating the Clinical Utility of a Biomarker
Pletcher, M. J., & Pignone, M. P. (2011) · Circulation · doi:10.1161/circulationaha.110.943860 · Cited by 172
The use of high-sensitivity assays for C-reactive protein in clinical practice
Musunuru, K., Kral, B. G., Blumenthal, R. S., Fuster, V., Campbell, C. Y., Gluckman, T. J., Lange, R. A., Topol, E. J., Willerson, J. T., Desai, M. Y., et al. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1322 · Cited by 160
Retinal Microvascular Changes and Risk of Stroke
Cheung, C. Y.-L., Tay, W. T., Ikram, M. K., Ong, Y., Silva, D. A. D., Chow, K. Y., & Wong, T. Y. (2013) · Stroke · doi:10.1161/strokeaha.113.001738 · Cited by 144
Aging and Inflammation in Two Epidemiological Worlds
Gurven, M., Kaplan, H. S., Winking, J., Finch, C. E., & Crimmins, E. M. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.2.196 · Cited by 142
Screening Asymptomatic Adults With Resting or Exercise Electrocardiography: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Arora, B., Dana, T., Fu, R. F., Walker, M., & Humphrey, L. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-6-201109200-00006 · Cited by 136
Early origins of inflammation: An examination of prenatal and childhood social adversity in a prospective cohort study
Slopen, N. B., Loucks, E. B., Appleton, A. A., Kawachi, I. I., Kubzansky, L. D., Non, A. L., Buka, S. L., & Gilman, S. E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.016 · Cited by 138
Well‐being, health‐related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease – a community‐based study
Bell, R. J., Rivera‐Woll, L., Davison, S. L., Topliss, D. J., Donath, S. M., & Davis, S. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02771.x · Cited by 129
Insulin Resistance and Risk Factors for Cardiovascular Disease in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Oeffinger, K. C., ADAMS-HUET, B. A., Victor, R. G., Church, T. S., Snell, P. G., Dunn, A. L., Eshelman‐Kent, D. A., Ross, R., Janiszewski, P. M., Turoff, A. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7251 · Cited by 130
Circulating microRNAs predict future fatal myocardial infarction in healthy individuals – The HUNT study
Bye, A., Røsjø, H. R., Nauman, J., da Silva, G. J. J., Follestad, T., Omland, T., & Wisløff, U. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.05.009 · Cited by 130
Assessing New Biomarkers and Predictive Models for Use in Clinical Practice
McGeechan, K., Macaskill, P., Irwig, L., Liew, G., & Wong, T. Y. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2304 · Cited by 132
Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality: Implications for Longevity
Ridker, P. M. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00372.x · Cited by 132
C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
Sattar, N. A., Murray, H. M., McConnachie, A., Blauw, G. J., Bollen, E. L. E. M., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643114 · Cited by 129
Cardiovascular Biomarkers: Tools for Precision Diagnosis and Prognosis
Netala, V. R., Hou, T., Wang, Y., Zhang, Z., & Teertam, S. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073218 · Cited by 143
Risk prediction models of breast cancer: a systematic review of model performances
Anothaisintawee, T., Teerawattananon, Y., Wiratkapun, C., Kasamesup, V., & Thakkinstian, A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1853-z · Cited by 122
Performance of reclassification statistics in comparing risk prediction models
Cook, N. R., & Paynter, N. P. (2011) · Biometrical Journal · doi:10.1002/bimj.201000078 · Cited by 121
How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators
Cooney, M. T., Dudina, A., De Bacquer, D., Fitzgerald, A., Conroy, R., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., et al. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283213140 · Cited by 121
Biomarkers and Cardiovascular Risk Assessment for Primary Prevention: An Update
Gilstrap, L. G., & Wang, T. J. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165712 · Cited by 122
Inflammation and reactivation of latent herpesviruses in older adults
Bennett, J. M., Glaser, R., Malarkey, W. B., Beversdorf, D. Q., Peng, J., & Kiecolt-Glaser, J. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.007 · Cited by 118
Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study
Conen, D., Ridker, P. M., Buring, J. E., & Glynn, R. J. (2007) · BMJ · doi:10.1136/bmj.39269.672188.ae · Cited by 119
Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults
Rodondi, N., Locatelli, I., Aujesky, D., Butler, J., Vittinghoff, E., Simonsick, E. M., Satterfield, S., Newman, A. B., Wilson, P. W. F., Pletcher, M. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034287 · Cited by 123
Epidemiology, risk factors and management of cardiovascular diseases in IBD
Singh, S., Kullo, I. J., Pardi, D. S., & Loftus, E. V. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.202 · Cited by 116
Increased levels of the inflammatory biomarker C‐reactive protein at baseline are associated with childhood sickle cell vasocclusive crises
Krishnan, S., Setty, Y. B. N., Betal, S. G., Vaidyula, V. R., Rao, K., Dampier, C., & Stuart, M. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08013.x · Cited by 118
Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus
Davis, T. M. E., Coleman, R. L., & Holman, R. R. (2013) · Circulation · doi:10.1161/circulationaha.112.000908 · Cited by 115
Multimarker Prediction of Coronary Heart Disease Risk
Kim, H. C., Greenland, P., Rossouw, J. E., Manson, J. E., Cochrane, B. B., Lasser, N. L., Limacher, M. C., Lloyd‐Jones, D. M., Margolis, K. L., & Robinson, J. G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.047 · Cited by 113
The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial
Atkin, M., Laight, D. W., & Cummings, M. H. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.003 · Cited by 115
Coronary Artery Disease in Women: A 2013 Update
Sharma, K., & Gulati, M. (2013) · Global Heart · doi:10.1016/j.gheart.2013.02.001 · Cited by 115
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
KONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 112
Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis
Sun, H., & Tian, F. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318792952 · Cited by 111
Inflammatory markers in coronary heart disease
Madjid, M., & Willerson, J. T. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr043 · Cited by 114
Chronic Conditions and Mortality Among the Oldest Old
Lee, S. J., Go, A. S., Lindquist, K. J., Bertenthal, D., & Covinsky, K. E. (2008) · American Journal of Public Health · doi:10.2105/ajph.2007.130955 · Cited by 114
Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study
Meyer, J. M., McEvoy, J. P., Davis, V. G., GOFF, D. C., Nasrallah, H. A., Thomas, S., Hsiao, J., Swartz, M. S., Stroup, T. S., & Lieberman, J. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.005 · Cited by 109
Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals
Karelis, A. D., & RABASA-LHORET, R. P. R. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.11.004 · Cited by 104
Markers of Atherosclerosis and Inflammation for Prediction of Coronary Heart Disease in Older Adults
Rodondi, N., Marques-Vidal, P. M., Butler, J., Sutton-Tyrrell, K., Cornuz, J., Satterfield, S., Harris, T. B., Bauer, D. C., Ferrucci, L., Vittinghoff, E., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp428 · Cited by 104

Authors: Cook, N. R., Buring, J. E., & Ridker, P. M.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Cook, Nancy R.
Buring, Julie E.
Ridker, Paul M
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2006-07-04
Volume: 145
Issue: 1
Pages: 21-29
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-145-1-200607040-00128
OpenAlex: W2100083473
Cited by: 504
References: 50
Citations by year: 2026: 2 · 2025: 7 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 13 · 2018: 14 · 2017: 9 · 2016: 19 · 2015: 23 · 2014: 21 · 2013: 31 · 2012: 35
FWCI: 58.97
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
Funders: National Institutes of Health (5r01hl043851-10)
National Heart, Lung, and Blood Institute (HL43851)
National Cancer Institute (CA-47988, R01CA047988)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: high-sensitivity C-reactive protein, cardiovascular risk prediction, women, 10-year cardiovascular risk, risk reclassification, model discrimination, concordance index, myocardial infarction, stroke, cardiovascular mortality, Women's Health Study
MeSH terms: Age Factors, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Lipids, Middle Aged, Smoking, United States, Cohort Studies, Biomarkers, Proportional Hazards Models, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks